baber/WOPTO huggingface dataset:
Patent IL-89929-A0 (IL)
Title: Beta-lactam derivatives,their preparation and pharmaceutical compositions containing them
IPC: C07D501/20
Filed: 1989-04-12
Abstract: There are provided compounds of the formula Ia and Ib <CHEM>  wherein A is hydrogen atom or an organic residue,  R<1> is halogen atom, or an organic group,  R<2> is hydrogen or halogen atom, C1-C4 alkyl or alkoxy group R<3> is hydrogen atom, C1-C4 alkyl or alkoxy group, benzyl or a methylene group and R4 is an organic residue. Said derivatives (Ia) and (Ib) are endowed with elastase inhibitory activity. A two-step process for their preparation starting from the corresponding 4-carboxy cephem or 3-carboxy penam is also provided.
Patent IL-90528-A0 (IL)
Title: Propanolamine derivatives,their preparation and pharmaceutical compositions containing them
IPC: A61K31/22
Filed: 1989-06-05
Abstract: The propanolamine derivatives of the formula 
<IMAGE>
 in which R<1>, R<2>, R<3> and R<4> have the meanings indicated in the description, and the physiologically tolerated salts thereof have catabolic action and can be used for treating obesity, diabetes and conditions associated with increased protein breakdown, or as feed additive for fattening livestock. 
<??>They can be prepared by reduction of appropriate monoester monoamides of malonic acid or corresponding propanolamides.
Patent IL-90607-A0 (IL)
Title: Pyrethroids and their use for controlling pests
IPC: C07D207/325
Filed: 1989-06-14
Abstract: Benzyl esters of the formula I   <IMAGE> (I)  where R1 is methyl, ethyl, halogen, methoxy or ethoxy, R2 is alkyl, alkenyl, cycloalkyl, cycloalkenyl, bicycloalkyl, bicycloalkenyl, C1-C5-alkyl-substituted cycloalkyl, C1-C5-substituted cycloalkenyl, C1-C5-alkyl-substituted bicycloalkyl or C1-C5-alkyl-substituted bicycloalkenyl, R3 is hydrogen, cyano, C2-C4-alkynyl, C2-C4-alkenyl or C1-C4-alkyl, A is the carboxylate radical of an acid component typical for pyrethroids and X is hydrogen or halogen, with the proviso that R2 is not CH2-CH=CH-B when B is hydrogen, alkyl or alkenyl and at the same time R1 is methyl or halogen, and furthermore with the proviso that R2 is not methyl when R1 is methyl, their manufacture, their use for combating pests, and precursors for manufacturing the benzyl esters.
Patent IL-90933-A0 (IL)
Title: Novel colored lens and method of manufacture
IPC: B29C37/00
Filed: 1989-07-11
Abstract: A process for the manufacture of a molded contact lens containing a transparent central visual region circumscribed by a colored iris portion which comprises   a. coating a colored liquid which is either curable or thermoplastic in a mold for making a contact lens onto a surface thereof where the iris portion of the lens is formed to produce a colored film thereon which film contains a surface exposed to the interior of the mold and a surface in contact with the mold, b. charging the mold with the resin used to form the body of the lens while maintaining the colored film in the iris portion and configuring the resin about the colored film whereby the surface of the film becomes integral with the body of the lens and the surface of the film becomes part of the outer surface of the lens when the molded lens is removed from the mold. o
Patent IL-91483-A0 (IL)
Title: Method of identifying spectra
IPC: G06Q50/00
Filed: 1989-08-31
Abstract: A method is described for establishing a hierarchial library of spectra representing the point-by-point characteristics of known samples. Vectors representing each spectrum are classified according to their similarity and dissimilarity. Vectors representing unknown samples are compared to known groups of vectors according to similarity until a near match is found.
Patent IL-94874-A0 (IL)
Title: (alpha-(tert.butyl aminomethyl)-3,4-dichlorobenzyl)-thioacetamide,its preparation and pharmaceutical compositions containing it
IPC: A61P3/02
Filed: 1990-06-26
Abstract: [ alpha -(tert-Butylaminomethyl)-3,4-dichlorobenzyl]thioacetamide of formula: <IMAGE>  and its addition salts with pharmaceutically acceptable acids. These compounds can be employed as antidepressants and for promoting food intake.
Patent SE-9400450-A0 (SE)
Title: Preparation and application of artificial anti-idiotypic antibodies obtained by molecular imprinting
Inventor: MOSBACH KLAUS
IPC: G01N33/68
Filed: 1994-02-10
Abstract: This patent application describes the use of molecular imprinting as a means for preparation of anti-idiotypic imprint matrices. With this technique, imprints of artificial or natural molecules including their recognition sites, such as of molecularly imprinted polymers or biological receptors, antibodies or enzymes, can be prepared. In the former case, using the original imprints as casts or molds in a subsequent polymerisation step, utilising preferentially functionally complementary monomers, the formation of imprint materials containing recognition sites complementary in shape and functionality with the original imprint can be obtained but being of different composition. Alternatively, imprints or images of the artificial or biological species can be obtained directly. The so formed preparations can be used in a vast variety of appolications, e.g. as new drugs, inhibitors or new affinity materials. <IMAGE>
Patent FI-20020793-A0 (FI)
Inventor: VIITAMAEKI TAPIO
IPC: F01C1/344
Filed: 2002-04-24
Abstract: The invention relates to a hydraulic motor having an outer casing and eccentric means for rotating a power shaft by means of fluid through a pressure chamber arrangement. The eccentric means comprise an eccentric part formed in the power shaft, a first eccentric ring between the outer casing and an inner casing, and a second eccentric ring mounted with bearings around the eccentric part and connected fixedly and concentrically to the first eccentric ring, whereby the pressure chamber arrangement is located between the first eccentric ring and the inner casing so that the first eccentric ring drives the power shaft through the second eccentric ring, and the eccentric rings form a substantially non-rotating entity that only performs an eccentric movement and by means of this eccentric movement rotates the power shaft.
Patent FI-20022048-A0 (FI)
Inventor: PULLI TIMO
IPC: G01N33/94
Filed: 2002-11-18
Abstract: A non-competitive immunoassay for small analytes, wherein the analyte is reacted with two binding partners. The first binding partner binds to the analyte to form a complex between the first binding partner and the analyte, and the second binding partner binds to the complex formed by the first binding partner and the analyte. The resulting complex formed between the analyte and the binding partners is detected. The binding partners are proteins, such as antibodies including antibody fragments.
Patent FI-20040105-A0 (FI)
Inventor: YLINEN JARI
IPC: B66B1/46
Filed: 2004-01-26
Abstract: The information about the allocation of the lifts are informed to the passengers based on the size and destination floor information of passengers which is input into a lift control system. An independent claim is also included for destination floor lift system.
Patent FI-20045268-A0 (FI)
IPC: B02C21/02
Filed: 2004-07-07
Abstract: A movable mineral material processing device comprising a feed hopper, whose walls (21, 22, 23) are arranged to be turned upward to a working position, and which are locked into said working position. To lock the walls (21, 22, 23), there is at least one locking means (L) in connection with them, said locking means containing at least a locking member (31) and transfer means (32). According to the method the locking member (31) is transferred to the locking position with the transfer means (32).
Patent FI-20055185-A0 (FI)
Inventor: AYRÄS JUKKA
IPC: B63B/
Filed: 2005-04-21
Abstract: A method and a building system for manufacturing a floating structure, for instance a watercraft, in which method the hull part for the floating structure is formed, it is provided with deck structures or similar support structures, and space units are prefabricated and installed between said deck structures or similar support structures. In the method such space units are manufactured, which comprise engineering units, which are provided at least with WC-equipment, as well as room units so that an engineering unit interconnected with a room unit forms a cabin unit. The engineering units of two adjacent cabin units are prefabricated and joined together to form an engineering unit pair and the thus accomplished engineering unit pair is transferred to and installed in its place on the floating structure. Further, the floating structure is provided with a number of vertical support elements, such as stanchions, to be installed between the deck structures, preferably prior to the installation of the engineering units.
Patent FI-20075237-A0 (FI)
Inventor: NIEMINEN ERKKA
IPC: D21B/
Filed: 2007-04-05
Abstract: An injector for a flotation cell, comprising a feed channel for feeding a fiber suspension flow to the flotation cell, a flow distribution element for distributing the fiber suspension flow fed to the injector into partial flows, a mixing apparatus for mixing air with the fiber suspension flow, and at least one air input point for sucking air to be mixed with the fiber suspension flow into the injector. The feed channel, the flow distribution element and the mixing apparatus are in the injector arranged with respect to one another such that a flow direction of the fiber suspension flow in the feed channel is substantially opposite to a flow direction of the fiber suspension flow through the flow distribution element and the mixing apparatus.
Patent IL-100550-A0 (IL)
Title: Synergistic pharmaceutical cosmetic compositions for treating herpes infections
IPC: A61P43/00
Filed: 1991-12-30
Abstract: Disclosed herein is a combination of an antiviral nucleoside analog and a ribonucleotide reductase inhibiting peptide derivative. The combination is useful for treating herpes infections.
Patent IL-110711-A0 (IL)
Title: 2 beta-alkenyl-penam derivatives, their preparation and pharmaceutical compositions containing them
IPC: C07D499/897
Filed: 1994-08-18
Abstract: The present invention relates to penem derivatives, especially to 3 beta -alkenyl-penem derivatives of the general formula <IMAGE>  wherein   one of R<1> and R<2> is -COR<4>, -CN, -CH2R<5>, halogen, -CH=CHR<6> or Q and the other is hydrogen or lower alkyl or both together are a gamma -lactam ring, R<3> is hydrogen, lower alkyl, arylalkyl, allyl or a radical which can be removed in vivo, R<4> is hydrogen, lower alkyl, lower alkoxy, benzyloxy, amino, lower alkylamino or lower alkyl-lower alkoxyamino, R<5> is hydroxyl, -OCONHR<7>, -OCONH2 or a five- or six-membered heteroaromatic ring containing N, S and/or O and linked via a nitrogen atom,   R<6> is -CN or -CHO,   R<7> is COCH2Cl, Q is a five- or six-membered heteroaromatic ring containing N, S and/or O and   n is 0, 1 or 2,  and the pharmaceutically tolerable salts of these compounds. These compounds are good  beta -lactamase inhibitors. They can be used, if appropriate mixed with a  beta -lactam antibiotic, for the prevention or for the treatment of bacterial infections.
Patent IL-111171-A0 (IL)
Title: Tissue inhibitor metalloproteinase type three (timp-3) composition and methods
IPC: C12N1/21
Filed: 1994-10-04
Abstract: Provided herein are metalloproteinase inhibitors and polynucleotides encoding such factors. In particular, provided herein are novel mammalian tissue inhibitors of metalloproteinase (designated as type three, or "TIMP-3"), fragments, derivatives, and analogs thereof, polynucleotides encoding the same and methods of producing recombinant TIMP-3's. In a further aspect, pharmaceutical compositions and kits containing TIMP-3's and their use for treating disorders are provided herein. In yet another aspect, antibodies selectively binding TIMP-3's are provided.
Patent IL-116385-A0 (IL)
Title: Sulphonamides their manufacture and pharmaceutical compositions containing them
IPC: A61K31/00
Filed: 1995-12-14
Abstract: PCT No. PCT/EP95/04843 Sec. 371 Date Aug. 15, 1997 Sec. 102(e) Date Aug. 15, 1997 PCT Filed Dec. 8, 1995 PCT Pub. No. WO96/19459 PCT Pub. Date Jun. 27, 1996Compounds of the formula: where A, B, R1-R8 are as described herein are endothelin inhibitors that can be used in treating diseases associated with endothelin, such as high blood pressure. Chemical synthesis of these compounds and pharmaceutical compositions containing these compounds are also useful.
Patent IL-123278-A0 (IL)
Title: Apparatus and method for digital data transmission
IPC: H04L5/02
Filed: 1996-07-25
Abstract: A method and apparatus for carrying out synchronous co-division multiple access (SCDMA) communication of multiple channels of digital data over a shared transmission media (1162). The system includes modems at remote units (1164) and a central unit (1160) to receive time division multiplexed digital data arranged into timeslots or channels and uses orthogonal codes to encode each channel of multiple data and spread the energy of each channel data over a frame of data transmitted in a code domain. Frames are synchronized as between remote (1164) and central units (1160) using a ranging scheme which is also useful in any other system transmitting data by frames in a distributed system where synchronizing the frames as between all units regardless of differences in propagation delays is necessary. Each frame in the SCDMA modulation scheme includes a gap or guardband containing no other data.
Patent IL-124414-A0 (IL)
Title: A method and apparatus for making a hypermedium interactive
IPC: G06F12/00
Filed: 1996-11-08
Abstract: A system and method of making a hypermedium page interactive. In one embodiment the system includes a hyperlink on the hypermedium page displayed on a client node; a hyperlink configuration file (corresponding to the hyperlink on the client node) located on a network server node; and a client agent located on the client node. In response to a user selecting the hyperlink on the hypermedium page, the client agent establishes a communications link from the client agent to an application execution server agent on an application server using the information located in the configuration file obtained from the network server node. In response to the creation of the communications link between the application execution server agent and the client agent, the application executes on the application execution server and the user is capable of interactively using the application running on the application execution node from the client node. Data input and display occurs at the client node under the control of the client agent. <IMAGE>
Patent IL-129928-A0 (IL)
Title: Aryl and heteroaryl substituted fused pyrrole antiinflammatory agents
IPC: A61P9/10
Filed: 1997-11-18
Abstract: The present invention comprises a new class of novel aryl and heteroaryl substituted fused pyrrole compounds useful for the prophylaxis and treatment of diseases or conditions, such as TNF-alpha, IL-1beta, IL-6 and/or IL-8 mediated diseases, and other maladies, such as pain and diabetes. In particular, the compounds of the invention are useful for the prophylaxis and treatment of diseases or conditions involving inflammation. Accordingly, the invention also comprises pharmaceutical compositions comprising the compounds of the invention, methods for the prophylaxis and treatment of inflammation and other maladies, such as pain and diabetes, using the compounds and compositions of the invention, and intermediates and processes useful for the preparation of compounds of the invention. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.
Patent IL-131348-A0 (IL)
Title: Treatment and prevention of adhesions
IPC: A61P17/02
Filed: 1998-02-11
Abstract: An inhibitor of adhesion formation which can be used to prevent adhesions within the abdominal cavity, particularly following surgical intervention, trauma or inflammation in the area is disclosed. Specifically, the most preferred compound of the present invention. Halofuginone, can be used to prevent collagen deposition from occurring within the peritoneum after surgical intervention, thereby inhibiting adhesion formation. Halofuginone, and related compounds, are useful in the prevention and treatment of both inflammatory and surgically induced adhesions, and in the treatment of congenital adhesions.
Patent IL-133508-A0 (IL)
Title: Pharmaceutical composition having enhanced antitumor activity and/or reduced side effects, containing an antitumor agent and a hydroximic acid derivative
IPC: A61K31/4545
Filed: 1998-06-22
Abstract: Pharmaceutical compositions that exhibit reduced gastrointestinal side-effects comprising a known active substance having antitumor effects selected from the group consisting of pyrimidine derivatives, or a pharmaceutically acceptable acid addition salt thereof, and O-(3-piperidino-2-hydroxy-1-propyl)nicotinic acid amidoxime, or a pharmaceutically acceptable acid addition salt thereof, are disclosed.
Patent IL-136307-A0 (IL)
Title: A package for a vaginal ring
IPC: B65D81/20
Filed: 1998-12-08
Abstract: An excellent package for a medicated vaginal ring has been found, comprising reclosable strip (E) and being made of a three-layer laminate. The laminate has a sealing layer, preferably LDPE, a barrier layer, preferably aluminium, and a damage protective layer, preferably PET. The reclosable strip (E) is a plastic rib-and-groove structure.
Patent IL-136690-A0 (IL)
Title: Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas
IPC: C07D241/12
Filed: 1998-12-22
Abstract: This invention relates to the use of a group of aryl ureas in treating raf mediated diseases, and pharmaceutical compositions for use in such therapy.
Patent IL-139963-A0 (IL)
Title: SUBSTITUTED β-DIKETONES AND THEIR USE
IPC: A61P11/00
Filed: 1999-06-30
Abstract: The invention relates to the compounds of formula I:wherein one of X1 and X2 is MeSO2 and the other one is hydrogen or halogen and X3 is hydrogen or halogen. These compounds have been found to be useful in the prevention and the treatment of respiratory diseases, especially asthma, ARDS (Acute Respiratory Distress Syndrome), COPD (chronic obstructive pulmonary diseases), allergic rhinitis and related inflammatory conditions. More specifically, the invention relates to the use of said compound in the prevention and the treatment of asthma in steroid-resistant patients. The invention also relates to pharmaceutical formulations used in the treatment of said diseases.
Patent IL-146620-A0 (IL)
Title: Method and system for creation and use of a photo album
IPC: B41J21/16
Filed: 2000-05-24
Abstract: A system for capturing an electronic message is disclosed. The system includes a printer, a sensing device and a computer system. The printer prints on a substrate user information visible to a user and coded tags invisible to the user. Each coded tag encodes an identity unique to the substrate and a location of the coded tag on the substrate. The user information defines a message area on the substrate. The sensing device senses the coded tags on the substrate when the sensing device is moved relative to the substrate. The computer system electronically captures a message composed with the sensing device via movement of the sensing device relative to the message area, the computer system using the identity of the substrate and a sequence of respective locations of coded tags sensed by the sensing device for determining the movement relative to the message area and the message.
Patent IL-149877-A0 (IL)
Title: Surveillance of the quality of service in a digital television link
IPC: H04H20/12
Filed: 2000-11-08
Abstract: The quality of service in a digital television link is monitored cyclically by means of an analyzer which analyzes the transport stream packets to deduce therefrom many standardized analysis parameters which are complex to interpret. The invention minimizes the number of measurements of these parameters by preselecting first and second analysis parameters and periodically determining a first maximum for variations from the first selected parameters and a second maximum for variations from the second parameters selected to deduce therefrom, respectively, a first parameter which is representative of the synchronization relative to the equipment units in the link and at least one second parameter which is representative of a degradation in a link.
Patent IL-152904-A0 (IL)
Title: Utilization of retinoid and vitamin d receptor antagonists for expansion of renewable stem cell populations
IPC: A61K35/12
Filed: 2002-11-17
Abstract: The present invention relates to an ex vivo method of expanding a population of cells ex-vivo, while at the same time, substantially inhibiting differentiation of the cells ex-vivo the method comprising: (a) culturing said cells under conditions which allow proliferation of said cells, and (b) ex-vivo providing said cells at the same time with added Nicotinamide, thereby ex-vivo expanding the population of cells while substantially inhibiting differentiation of the cells ex-vivo.
Patent IL-155002-A0 (IL)
Title: Reduced-viscosity concentrated protein formulations
IPC: A61K38/16
Filed: 2001-10-04
Abstract: The present application concerns concentrated protein formulations with reduced viscosity, which are particularly suitable for subcutaneous administration. The application further concerns a method for reducing the viscosity of concentrated protein formulations.
Patent IL-159572-A0 (IL)
Title: Foreign body retrieval device
IPC: A61B17/22
Filed: 2001-06-28
Abstract: A surgical device for removing a foreign object from a body is described. The device includes a retrieval basket for entrapping and retaining the object located in the body, a basket control assembly comprising a tubular sheath adapted to penetrate into the body for reaching the object, and a manipulator for manipulating the basket for extraction the object from the body. The basket comprises a structure having a proximal end and a distal end. The structure is formed by a plurality of filaments fabricated from a single or several wires. The filaments extend from the proximal end towards the distal end. At least a part of the filaments are configured in the form of loops. At least a part of the loops are interlaced so as to define a net at the distal end, and thereby impart structural rigidity and dilatation ability to the basket when opened.
Patent IL-165939-A0 (IL)
Title: Signal processing with channel eigenmode decomposition and channel inversion for mimo systems
IPC: H04L1/00
Filed: 2004-12-22
Abstract: Techniques for processing a data transmission at a transmitter and receiver, which use channel eigen-decomposition, channel inversion, and (optionally) 'water-pouring'. At the transmitter, (1) channel eigen-decomposition is performed to determine eigenmodes of a MIMO channel and to derive a first set of steering vectors, (2) channel inversion is performed to derive weights ( e . g ., one set for each eigenmode) used to minimize ISI distortion, and (3) water-pouring may be performed to derive scaling values indicative of the transmit powers allocated to the eigenmodes. The first set of steering vectors, weights, and scaling values are used to derive a pulse-shaping matrix, which is used to precondition modulation symbols prior to transmission. At the receiver, channel eigen-decomposition is performed to derive a second set of steering vectors, which are used to derive a pulse-shaping matrix used to condition received symbols such that orthogonal symbol streams are recovered.